Literature DB >> 12823495

Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives.

L L Thomsen1, J Olesen, M B Russell.   

Abstract

We investigated the occurrence of migraine without aura (MO) and migraine with typical aura (MA) amongst probands with familial hemiplegic migraine (FHM) and their first degree relatives in order to evaluate the relations between these syndromes. A total of 44 FHM probands and 240 first degree relatives were identified in the Danish population. The pattern of familial aggregation was assessed by population relative risk (PRR) calculations. Amongst FHM probands the PRR of MO was 1.5 (95% CI: 0.8-2.2), whereas the PRR of MA was 7.1 (95% CI: 5.0-9.2). Thus, compared with the general population, FHM probands had no increased risk of MO but a significantly increased risk of MA. A similar pattern was seen amongst their first degree relatives, who had no increased risk of MO, whereas the risk of MA was significantly increased; 7.6 times in FHM-affected first degree relatives and 2.4-times in non-FHM-affected first degree relatives. These results are contrary to a sharing of genetic mechanisms between FHM and MO. Furthermore, they suggest that the genetic abnormality causing FHM may also cause attacks with the symptomatology of MA.

Entities:  

Mesh:

Year:  2003        PMID: 12823495     DOI: 10.1046/j.1468-1331.2003.00621.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  12 in total

Review 1.  Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS.

Authors:  Sanjeev Rajakulendran; Diego Kaski; Michael G Hanna
Journal:  Nat Rev Neurol       Date:  2012-01-17       Impact factor: 42.937

2.  Lack of association between urotensin-II (UTS2) gene polymorphisms (Thr21Met and Ser89Asn) and migraine.

Authors:  Betül Ozan; Seniz Demiryürek; Muhammad Safdar; Yusuf Inanc; Abdullah Tuncay Demiryürek
Journal:  Bosn J Basic Med Sci       Date:  2017-08-20       Impact factor: 3.363

Review 3.  Insights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine.

Authors:  Daniela Pietrobon
Journal:  J Physiol       Date:  2010-03-01       Impact factor: 5.182

4.  Familial risks for migraine and other headaches among siblings based on hospitalizations in Sweden.

Authors:  Kari Hemminki; Xinjun Li; Sven-Erik Johansson; Kristina Sundquist; Jan Sundquist
Journal:  Neurogenetics       Date:  2005-10-19       Impact factor: 2.660

Review 5.  Toward a molecular genetic classification of familial hemiplegic migraine.

Authors:  Joost Haan; Esther E Kors; Arn M J M van den Maagdenberg; Kaate R J Vanmolkot; Gisela M Terwindt; Rune R Frants; Michel D Ferrari
Journal:  Curr Pain Headache Rep       Date:  2004-06

6.  Divergent sodium channel defects in familial hemiplegic migraine.

Authors:  Kristopher M Kahlig; Thomas H Rhodes; Michael Pusch; Tobias Freilinger; José M Pereira-Monteiro; Michel D Ferrari; Arn M J M van den Maagdenberg; Martin Dichgans; Alfred L George
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-09       Impact factor: 11.205

7.  Familial and sporadic hemiplegic migraine: diagnosis and treatment.

Authors:  Nadine Pelzer; Anine H Stam; Joost Haan; Michel D Ferrari; Gisela M Terwindt
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

8.  Familial Aggregation of Migraine and Depression: Insights From a Large Australian Twin Sample.

Authors:  Yuanhao Yang; Huiying Zhao; Andrew C Heath; Pamela A F Madden; Nicholas G Martin; Dale R Nyholt
Journal:  Twin Res Hum Genet       Date:  2016-06-06       Impact factor: 1.587

9.  Migraine and behavior in children: influence of maternal headache frequency.

Authors:  Marco A Arruda; Marcelo E Bigal
Journal:  J Headache Pain       Date:  2012-03-30       Impact factor: 7.277

Review 10.  Familial hemiplegic migraine.

Authors:  Daniela Pietrobon
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.